<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(9)</volume><submitter>Miller JJ</submitter><funding>American Cancer Society</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>American Academy of Neurology</funding><journal>Expert opinion on investigational drugs</journal><pagination>1007-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5018991</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Perspectives on investigational drugs and immunotherapies for glioblastoma.</pubmed_title><pmcid>PMC5018991</pmcid><funding_grant_id>R01 CA190901</funding_grant_id><pubmed_authors>Dietrich J</pubmed_authors><pubmed_authors>Miller JJ</pubmed_authors><pubmed_authors>Curry WT</pubmed_authors><pubmed_authors>Cahill DP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Perspectives on investigational drugs and immunotherapies for glioblastoma.</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Sep</publication><modification>2025-05-29T16:17:01.06Z</modification><creation>2025-04-05T20:35:14.78Z</creation></dates><accession>S-EPMC5018991</accession><cross_references><pubmed>27415034</pubmed><doi>10.1080/13543784.2016.1213242</doi></cross_references></HashMap>